Learn more

NOVARTIS AG

Overview
  • Total Patents
    48,241
  • GoodIP Patent Rank
    117
  • Filing trend
    ⇧ 7.0%
About

NOVARTIS AG has a total of 48,241 patent applications. It increased the IP activity by 7.0%. Its first patent ever was published in 1978. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are DAIICHI SUNTORY PHARMA CO LTD, NOVARTIS INT PHARM LTD and PROTARGA INC.

Patent filings in countries

World map showing NOVARTIS AGs patent filings in countries
# Country Total Patents
#1 EPO (European Patent Office) 4,830
#2 WIPO (World Intellectual Property Organization) 3,926
#3 United States 3,601
#4 Australia 3,495
#5 China 3,382
#6 Canada 3,106
#7 Brazil 2,252
#8 Republic of Korea 2,222
#9 Mexico 1,894
#10 Israel 1,467
#11 Taiwan 1,439
#12 United Kingdom 1,429
#13 Argentina 1,084
#14 Japan 904
#15 New Zealand 894
#16 South Africa 892
#17 Russian Federation 839
#18 Peru 757
#19 Norway 697
#20 Hong Kong 684
#21 Singapore 678
#22 Hungary 581
#23 Chile 555
#24 Tunisia 511
#25 Morocco 503
#26 Colombia 467
#27 Ecuador 449
#28 Malaysia 394
#29 Poland 389
#30 Uruguay 306
#31 Czechia 271
#32 EAPO (Eurasian Patent Organization) 261
#33 Slovakia 227
#34 Costa Rica 222
#35 Philippines 204
#36 Cuba 202
#37 Jordan 168
#38 Ukraine 146
#39 African Regional Industrial Property Organization 123
#40 Serbia 122
#41 Indonesia 120
#42 Germany 116
#43 Finland 110
#44 India 94
#45 Netherlands 83
#46 Guatemala 79
#47 Dominican Republic 71
#48 Denmark 62
#49 Honduras 62
#50 Slovenia 62
#51 El Salvador 61
#52 Ireland 59
#53 Cyprus 58
#54 Nicaragua 52
#55 Iceland 50
#56 Luxembourg 50
#57 Montenegro 50
#58 Portugal 48
#59 Saudi Arabia 48
#60 Georgia 36
#61 Egypt 32
#62 Croatia 31
#63 France 29
#64 Republic of Moldova 26
#65 Bulgaria 22
#66 Lithuania 20
#67 Panama 20
#68 Belgium 18
#69 Italy 18
#70 Estonia 16
#71 Switzerland 12
#72 Greece 10
#73 Spain 9
#74 Sweden 9
#75 Yugoslavia (Serbia and Montenegro) 7
#76 Romania 6
#77 Austria 3
#78 Turkey 3
#79 African Intellectual Property Organization 2
#80 Tajikistan 2
#81 Bosnia and Herzegovina 1
#82 Algeria 1

Patent filings per year

Chart showing NOVARTIS AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Furet Pascal 1,004
#2 Fairhurst Robin Alec 501
#3 Bold Guido 419
#4 Manley Paul W 338
#5 Mutz Michael 322
#6 Sedelmeier Gottfried 321
#7 Leblanc Catherine 297
#8 Guagnano Vito 295
#9 Hurth Konstanze 287
#10 Garcia-Echeverria Carlos 287

Latest patents

Publication Filing date Title
WO2021078120A1 Compounds and compositions for the treatment of parasitic diseases
WO2021079195A1 Tim-3 inhibitors and uses thereof
WO2021079188A1 Combination therapies with venetoclax and tim-3 inhibitors
WO2021070090A1 2-azaspiro[3.4]octane derivatives as m4 agonists
WO2021070091A1 5-oxa-2-azaspiro[3.4]octane derivatives as m4 agonists
WO2021064695A1 Methods for measuring cralbp activity
WO2021064575A1 Treatment comprising the use of fxr agonists
WO2021061898A1 Antiviral pyrazolopyridinone compounds
WO2021057853A1 Aza-quinoline compounds and uses thereof
WO2021055820A1 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid and its salts formulation
WO2021053591A1 Methods of treating autoimmune diseases using interleukin-17 (il-17) antagonists
WO2021053617A1 Mll1 inhibitors and anti-cancer agents
WO2021053618A1 Treatment comprising fxr agonists
WO2021053559A1 Entpd2 antibodies, combination therapies, and methods of using the antibodies and combination therapies
WO2021053560A1 Combination therapy with entpd2 and cd73 antibodies
US2021077430A1 Combination therapy
WO2021053556A1 Nkg2d fusion proteins and uses thereof
WO2021053555A1 Glue degraders and methods of use thereof
WO2021053495A1 Bifunctional degraders and their methods of use
WO2021053489A1 Use of an mdm2 inhibitor for the treatment of myelofibrosis